Harvard Apparatus Regenerative Technology (Harvard Apparatus Regenerative Technology) Short Interest

View and export this data going back to 2013. Start your Free Trial

What is Harvard Apparatus Regenerative Technology Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Harvard Apparatus Regenerative Technology's Short Interest

For the Biotechnology subindustry, Harvard Apparatus Regenerative Technology's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harvard Apparatus Regenerative Technology's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Harvard Apparatus Regenerative Technology's Short Interest distribution charts can be found below:

* The bar in red indicates where Harvard Apparatus Regenerative Technology's Short Interest falls into.

Harvard Apparatus Regenerative Technology (Harvard Apparatus Regenerative Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Harvard Apparatus Regenerative Technology Inc (OTCPK:HRGN) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

N/A

Address

84 October Hill Road, Suite 11, Holliston, MA, USA, 01746

Website

https://www.biostage.com

Harvard Apparatus Regenerative Technology Inc is a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastrointestinal system and the airway resulting from cancer, trauma, or birth defects. The company's technology is based on its proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs.

Executives

Junli He	director	C/O NO.1, COUNTRY GARDEN ROAD, BEIJIAO TOWN, SHUNDE DISTRICT, FOSHAN F4 528300
James E. Shmerling	director	975 JOHNSON FERRY ROAD, SUITE 450, ATLANTA GA 30342
Dst Capital Llc	10 percent owner	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Ronald J Packard	director	2300 CORPORATE PARK DRIVE, HERNDON VA 20171
Jing Chen	director	C/O BIOSTAGE,INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 02110
Hong Yu	officer: President	C/O BIOSTAGE, INC. 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Damasio Joseph Luis Jr	officer: Chief Financial Officer	14 NORFOLK AVENUE, SOUTH EASTON MA 02375
David Green	director, officer: See Remarks	C/O HARVARD BIOSCIENCE INC, 84 OCTOBER HILL ROAD, HOLLISTON MA 01746-1371
William Fodor	officer: Chief Scientific Officer	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Peter A. Pellegrino	officer: Interim VP of Finance	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Herman Sanchez	director	84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON MA 01746
James Mastridge	officer: See Remarks	C/O BIOSTAGE, INC., 84 OCTOBER HILL RD., HOLLISTON MA 01746
Jeffrey E Young	director	60 WESTVIEW STREET, LEXINGTON MA 02421
Wei Zhang	director	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Ting Li	director	C/O BIOSTAGE, INC., 84 OCTOBER HILL RD., HOLLISTON MA 01746